Article Text
Abstract
In health outcomes terms, the poorest countries stand to lose the most from these disruptions. In this paper, we make the case for a rational approach to public sector health spending and decision making during and in the early recovery phase of the COVID-19 pandemic. Based on ethics and equity principles, it is crucial to ensure that patients not infected by COVID-19 continue to get access to healthcare and that the services they need continue to be resourced. We present a list of 120 essential non-COVID-19 health interventions that were adapted from the model health benefit packages developed by the Disease Control Priorities project.
- public health
- health policies and all other topics
- control strategies
- health economics
- health systems
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
Footnotes
Handling editor Seye Abimbola
Twitter @BlanchetKarl, @alemayehu4u2, @HangomaPeter, @davidawatkins, @KA_Johansson
Contributors KB, OFN, DW and KAJ designed the prioritisation process, drafted the various versions of the list of interventions and the paper. AJN, AH, CA, FF, IM, MJC, OH, PH, STM, SN and TAG reviewed the first list of interventions and reviewed the final list and the draft and final paper. AA, DJ and SV reviewed the final version of the list of interventions and the draft and final paper.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement All data relevant to the study are included in the article.